
Verrica Pharmaceuticals earnings, Revenue beat in Q3
Investing.com - Verrica Pharmaceuticals reported on Monday third quarter {{erl-1080049||earnings that beat analysts' forecasts and revenue that topped expectations. Verrica Pharmaceuticals...
Investing.com - Verrica Pharmaceuticals reported on Monday third quarter {{erl-1080049||earnings that beat analysts' forecasts and revenue that topped expectations. Verrica Pharmaceuticals...
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Consumer Services, Oil & Gas and Consumer Goods sectors propelled shares higher. At the close in NYSE,...
Pre-Open Stock Movers: Verrica Pharmaceuticals Inc. (Nasdaq: NASDAQ:VRCA) 54% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL)...
Investing.com – U.S. equities were higher at the close on Wednesday, as gains in the Oil & Gas, Technology and Consumer Services sectors propelled shares higher. At the close in NYSE, the...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.